诚如公司日期为2025年4月8日内容有关根据一般授权认股新股份(「认购事项」)的公告所披露，其中包 括公司拟将认购事项项下筹集之所得款项净额中的50%用于与中医药相关的新业务机会，包括投资中医 药制造厂商。 公司认为就位于香港并于香港设有生产线及销售点的传统中医药(TCM)制造厂商作出投资将令集团的销 售版图扩展至香港及海外。鉴于永盛为香港持牌中医药制造厂商，且其业务范围覆盖香港及澳门，董事 会认为收购事项符合集团发展战略。 格隆汇1月19日丨现代中药集团(01643.HK)宣布，于2026年1月19日，公司与卖方皇御控股有限公司订立 买卖协议，据此，公司有条件同意购买而卖方同意出售待售股份(300万股普通股，占目标公司数智健康 全球控股有限公司全部已发行股本的30%)，代价为4182万港元。 ...

去年刑事案件同比下降12.8%，为本世纪以来最低 据央视新闻客户端1月19日消息，中央政法工作会议1月18日至19日在京召开，记者从会上了解到，2025 年全国群众安全感为98.23%，连续6年保持在98%以上。全国刑事案件同比下降12.8%，为本世纪以来最 低。治安案件同比下降3.5%，社会治安形势持续向好。据悉，2025年政法机关打击电信网络诈骗犯罪 取得重大战果，毁灭性打击缅北"四大家族"犯罪集团，5.7万名犯罪分子移交回国，赌诈犯罪集团头目 陈志被押解回国。打击毒品犯罪取得历史性成就，全国吸毒人员较2020年底下降63%。2025年，检察机 关受理审查起诉未成年人犯罪人数和侵害未成年人犯罪人数同比分别下降9.8%和2.2%，首次实现"双下 降"。 信用修复人次连续7季度超过新纳入失信名单数 据最高人民法院1月19日消息，最高人民法院公布2025年司法审判工作主要数据。去年，人民法院受理 各类审判执行案件（不含先行调解成功案件，下同）3700余万件，同比增长超过10%。受理刑事一审案 件100余万件，判处生效被告人140余万人，案件数量和人数同比均下降。受理民商事一审案件2000余万 件，同比上升超过1 ...

齐鲁晚报·齐鲁壹点 夏侯凤超 于泊升 李梦瑶 杜春娜 石晟绮 王贝艺 1月19日，济南市第十八届人民代表大会第五次会议开幕，济南市市长于海田作政府工作报告。 报告提出，2026年济南市聚力深化改革扩大开放，打造一流营商环境。 推进深层次改革。全面落实中央和省委改革部署，实施好第三批自主改革任务。深化国资国企改革，加 快推进"五个转型"，强化穿透式监管，优化科技创新正向激励管理办法，市属企业战略性新兴产业营业 收入同比增长10%。深化省级以上开发区改革创新，突出经济发展主责主业，持续推进放权、赋能、减 负。扎实推进财政科学管理综合试点，全面推开零基预算改革，依法依规加强税费征管，切实增强财政 保障能力。 推进高水平对外开放。促进外贸提质增效，积极发展跨境电商、海外仓等新业态新模式，实施"泉品出 海"行动，扩大优势产品出口规模，加大高端装备、大宗商品进口力度，进出口增速高于全省平均水 平。鼓励中医药、建筑等传统优势服务出口，争创国家服务贸易创新发展示范区。开展"外贸优品中华 行"等活动，推动市场多元化和内外贸一体化。全面落实自贸试验区提升战略，深化新型跨境贸易等改 革试点，打造"山海经"出海综合服务港。健全完善综 ...

Emerging Fields - The release of 4 national standards for industrial internet platforms supports the scalable development and application of industrial internet platforms [1] - 4 national standards for digital supply chains are aimed at enhancing the resilience of industrial chains through digitalization [1] - 5 national standards for smart factory safety integration promote high-quality and sustainable development in manufacturing through data-driven management [1] - National standards for the classification and comprehensive utilization of recyclable rare earth secondary resources support the recycling of rare earth resources [1] Transportation and Green Low-Carbon - 23 national standards related to railway freight transport, intelligent transport, and aviation services facilitate efficient development in transportation [1] - 7 national standards for explosion-proof industrial vehicles and off-road forklifts promote the standardized development of the industrial vehicle sector [1] - 3 logistics national standards for multimodal transport service quality assessment and the integration of logistics and manufacturing industries guide the integration of transport modes [1] - 17 national standards for carbon capture, green factory evaluation, and greenhouse gas emission accounting assist in achieving carbon neutrality goals [1] Safety Production - 13 mandatory national standards for production safety accident investigation and economic loss statistics enhance safety emergency capabilities in hazardous chemical enterprises [2] - 4 mandatory national standards in the fire safety sector improve the fire performance and quality of building insulation materials and rescue equipment [2] - 28 national standards related to feed, pesticides, plant quarantine, and animal husbandry provide a technical foundation for agricultural production safety [2] Daily Life - 6 national standards for children's products, including portable baby sleep baskets and VOC emission measurement, aim to enhance product quality and safety [2] - 3 national standards for elderly care institutions standardize care practices and improve the quality of life services [2] - 5 national standards for traditional Chinese medicine better protect public health through classification and assessment [2] - 5 national standards for musical instruments, including pianos and electric instruments, cater to the cultural and spiritual needs of the public [2] - 2 mandatory national standards for sports venues, including climbing and fencing, ensure safety in fitness activities [2] Additional Standards - The market regulatory authority has also released national standards in areas such as government services, wind power generation systems, water conservation, and agricultural products [2]

（来源：劳动午报） 转自：劳动午报 近日，怀柔区雁栖镇社区卫生服务中心建成"中医药健康小院"，这也是该区首家中医药健康小院。 据介绍，中医药健康小院是北京市卫健委为发挥中医药在农村居民健康全周期中的作用，创新推出的农 村中医药服务模式。以"强基层、建机制、惠民生"为原则，建成集中医药专家健康咨询、中医适宜技术 推广、中医药知识与理念传播、中医药文化宣传于一体的综合区域，旨在推进农村中医药工作健康可持 续发展，不断提高农村居民健康水平。 走进位于雁栖镇范各庄社区卫生服务站院内的小院，功能完备的科室体系让人眼前一亮。中医诊室里， 医师精准辨证论治，为患者量身定制诊疗方案；中医治疗室内，针灸、推拿等传统技法为颈肩腰腿痛等 常见病症患者缓解不适；中医体验室通过趣味互动，让居民亲身感受中医药的独特魅力；科普宣教室 内，健康知识宣讲活动定期开展，为居民普及科学的中医药养生理念。各科室协同联动，形成了集诊 疗、康复、体验、宣教于一体的全链条中医药服务模式，可满足居民多样化健康需求。在此基础上，红 外线治疗仪、中医四诊仪、超声药物渗透仪等一系列现代化中医诊疗设备的引入，实现了中医传统诊断 与现代科技的深度融合。 专业的服务离 ...

Group 1 - The core viewpoint of the articles highlights Hong Kong's efforts to establish a robust framework for Traditional Chinese Medicine (TCM) to enhance its global presence and acceptance [1][2][3] Group 2 - Hong Kong has developed a regulatory system for TCM, including the establishment of the Hong Kong Chinese Medicine Standards and a Chinese Medicine Testing Center, which will begin phased operations in December 2025 [1] - The Hong Kong government has invested a total of 1 billion HKD in the Chinese Medicine Development Fund since 2019, supporting over 10 funding programs in training, research, public awareness, industry development, and quality enhancement [2] - As of November 2025, there are 10,842 registered Chinese medicine practitioners in Hong Kong, with over 90% practicing in the community, creating a strong grassroots healthcare network [2] Group 3 - The Hong Kong Chinese Medicine Hospital, set to begin phased services in December 2025, aims to promote TCM education, training, and research innovation, supporting clinical research and the development of Chinese patent medicines [2] - The TCM industry in Hong Kong actively organizes promotional activities, with government support for projects that enhance public understanding and recognition of TCM [2][3]

四师可克达拉市第二小学教师吴兰：镇江援疆医生、四师总医院中医科副主任丁小星近日来到我校，为 孩子们带来一堂生动有趣的中医药科普课。课堂上，丁医生以神农尝百草的传说为切入点，循序渐进地 讲解中医药的药食同源功效，并精心设计了趣味问答环节。孩子们热情高涨，积极踊跃举手参与互动。 此次援疆帮扶活动不仅为孩子们送来了优质的医疗服务，更为他们打开了一扇了解中华优秀传统文化的 大门，在青少年心中播下传统中医药文化的种子。（明辉 整理） ...

Core Viewpoint - The newly introduced "Regulations on the Promotion of Traditional Chinese Medicine Development in Zhengzhou" aims to enhance the accessibility and quality of TCM services, addressing issues such as uneven resource distribution and insufficient grassroots service capabilities, with implementation set for March 1, 2026 [1][2][3] Group 1: Service System - The regulations mandate the establishment of TCM clinics in community health service centers and township hospitals, and TCM corners in community health service stations and village clinics to improve grassroots medical institutions' TCM service capabilities [1] - The initiative focuses on meeting public health needs through a systematic approach that includes service system enhancement, industry development, talent inheritance, and digital empowerment [1] Group 2: Talent Development - The regulations emphasize building a TCM talent team led by top talents and including young, key, and practical talents, with plans to cultivate high-level talents through institutions like the "Central Plains Qihuang Academy" [1][2] - Zhengzhou has already attracted 14 high-end TCM talent teams, including academicians, and aims to enhance the quality and efficiency of TCM academic inheritance [1] Group 3: Digital Empowerment - A significant highlight of the regulations is the encouragement for TCM institutions to utilize modern information technologies, such as artificial intelligence, to provide integrated online and offline medical services [2] - Zhengzhou plans to establish a TCM digital service platform to expand applications in intelligent diagnostic assistance and personalized prescription optimization [2] Group 4: Industry Development - The regulations establish a collaborative mechanism for TCM industry development, creating a quality assurance system covering the entire industry chain from planting to research, production, and distribution [2] - Support is provided for medical institutions to create platforms for the transformation of TCM health products, leveraging professional advantages to develop health services related to dietary therapy, cultural creativity, and health care [2] Group 5: Long-term Vision - The legislative framework aims to transform policy deployment into legal systems, providing legal guarantees for the establishment of a national TCM inheritance and innovation development experimental zone and enhancing the quality of TCM services [3] - The regulations are designed to address current shortcomings while also focusing on long-term development, ensuring that TCM benefits a broader population and drives high-quality development in Zhengzhou [3]

Core Viewpoint - The Shandong Provincial Government is implementing a comprehensive reform plan to enhance the regulation of pharmaceuticals and medical devices, aiming to promote high-quality development in the pharmaceutical industry, which is crucial for national economy and security [1][2]. Group 1: Policy Initiatives - The Shandong Provincial Health Commission will utilize a combination of policy guidance, service optimization, and regulatory assurance to inject new momentum into the high-quality development of the pharmaceutical industry [1]. - A dynamic linkage mechanism will be established between hospital drug supply and the medical insurance drug catalog, facilitating the clinical application of innovative drugs [1]. Group 2: Clinical Evaluation and Support - A comprehensive clinical evaluation system will be developed to assess the safety, efficacy, economic viability, innovation, suitability, and accessibility of drugs, particularly focusing on conditionally approved innovative drugs [2]. - Clinical trial support capabilities will be enhanced by incorporating clinical research into the evaluation of public hospitals' quality, allowing for dedicated beds for innovative drug trials not to count towards total bed numbers [2]. Group 3: Traditional Medicine and Collaboration - The "Qilu Traditional Chinese Medicine Brand Project" will be implemented to promote the quality and added value of traditional Chinese medicine, including the establishment of ecological planting bases for medicinal materials [2]. - A regular consultation mechanism will be established among the Health Commission, Medical Insurance Bureau, and Drug Administration to facilitate data sharing and address cross-sector issues related to innovative drug evaluation and clinical application [3].

Core Viewpoint - The biopharmaceutical industry is at a pivotal moment as it transitions into the "15th Five-Year Plan," emphasizing the need for a balance between traditional practices and innovative approaches to ensure sustainable growth in the face of technological and capital cycles [1][2]. Group 1: Industry Context - The biopharmaceutical sector is experiencing rapid technological iterations, rational capital returns, and a deep restructuring of the global competitive landscape [2]. - The year 2026 is anticipated to be crucial for the integration of traditional Chinese medicine (TCM) into modern health practices, moving from confidence in heritage to a conscious engagement with contemporary scientific frameworks [8][9]. Group 2: Company Strategy - Hongmao Pharmaceutical, with nearly 300 years of history, aims to explore new paths for TCM development by balancing tradition and innovation, emphasizing the importance of both "guarding the essence" and "innovation" [1][2]. - The company is committed to modern clinical research to support traditional practices, transitioning TCM from experience-based to evidence-based approaches [4][5]. Group 3: Innovation and Technology - Hongmao is transforming from "manufacturing" to "intelligent manufacturing," utilizing digital traceability to ensure the authenticity of medicinal materials and implementing smart manufacturing for precision in processes [5][6]. - The integration of advanced technologies, such as artificial intelligence and real-world evidence, is seen as essential for developing a comprehensive evidence system from raw materials to clinical applications [9]. Group 4: Cultural Heritage and Industry Development - The company is focused on converting cultural heritage into industrial momentum, promoting standardized cultivation and traceability of medicinal materials while enhancing product quality through modern technology [6][7]. - The approach of "cultural empowerment of industry" aims to enhance brand competitiveness and inject vitality into local development, ensuring that cultural heritage serves contemporary needs [6][10]. Group 5: Future Outlook - The future of TCM is envisioned as a systemic reconstruction that roots itself in ancient wisdom while addressing modern health challenges, with a focus on preventive health measures [8][9]. - Hongmao aims to evolve from merely supplying products to empowering health, creating a comprehensive health service ecosystem that integrates medicine, health, and culture [7][9].